• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 细胞免疫缺陷的临床方面:过去、现在和未来。

Clinical Aspects of B Cell Immunodeficiencies: The Past, the Present and the Future.

机构信息

Division of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.

Department of Pediatrics, Northwestern University, Chicago, IL 60611, USA.

出版信息

Cells. 2022 Oct 24;11(21):3353. doi: 10.3390/cells11213353.

DOI:10.3390/cells11213353
PMID:36359748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9654110/
Abstract

B cells and antibodies are indispensable for host immunity. Our understanding of the mechanistic processes that underpin how B cells operate has left an indelible mark on the field of clinical pathology, and recently has also dramatically reshaped the therapeutic landscape of diseases that were once considered incurable. Evaluating patients with primary immunodeficiency diseases (PID)/inborn errors of immunity (IEI) that primarily affect B cells, offers us an opportunity to further our understanding of how B cells develop, mature, function and, in certain instances, cause further disease. In this review we provide a brief compendium of IEI that principally affect B cells at defined stages of their developmental pathway, and also attempt to offer some educated viewpoints on how the management of these disorders could evolve over the years.

摘要

B 细胞和抗体对于宿主免疫至关重要。我们对支撑 B 细胞运作的机制过程的理解,给临床病理学领域留下了不可磨灭的印记,最近也极大地改变了曾经被认为无法治愈的疾病的治疗格局。评估主要影响 B 细胞的原发性免疫缺陷病 (PID)/先天性免疫缺陷 (IEI) 患者,使我们有机会进一步了解 B 细胞如何发育、成熟、发挥功能,以及在某些情况下导致进一步的疾病。在这篇综述中,我们简要概述了主要影响 B 细胞在其发育途径特定阶段的 IEI,并试图就这些疾病的多年来的管理方法提供一些有根据的观点。

相似文献

1
Clinical Aspects of B Cell Immunodeficiencies: The Past, the Present and the Future.B 细胞免疫缺陷的临床方面:过去、现在和未来。
Cells. 2022 Oct 24;11(21):3353. doi: 10.3390/cells11213353.
2
Future of Therapy for Inborn Errors of Immunity.免疫先天缺陷治疗的未来。
Clin Rev Allergy Immunol. 2022 Aug;63(1):75-89. doi: 10.1007/s12016-021-08916-8. Epub 2022 Jan 12.
3
Updates on new monogenic inborn errors of immunity.新的单基因遗传性免疫缺陷的最新进展
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):57-59. doi: 10.1111/pai.13365.
4
Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.先天免疫缺陷的调理方案:当前的观点和未来的策略。
Int J Hematol. 2022 Jul;116(1):7-15. doi: 10.1007/s12185-022-03389-7. Epub 2022 Jun 8.
5
[Registry of Inborn errors of immunity in a pediatric hospital].[一家儿科医院的先天性免疫缺陷登记处]
Rev Alerg Mex. 2020 Jul-Sep;67(3):268-278. doi: 10.29262/ram.v67i3.738.
6
Clinical and Genetic Spectrum of Inborn Errors of Immunity in a Tertiary Care Center in Southern India.印度南部一家三级护理中心的先天性免疫缺陷的临床和遗传学特征。
Indian J Pediatr. 2022 Mar;89(3):233-242. doi: 10.1007/s12098-021-03936-w. Epub 2021 Nov 26.
7
Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity.提高对人类先天性免疫缺陷患者胃肠道表现认识的必要性。
Front Immunol. 2021 Aug 12;12:698721. doi: 10.3389/fimmu.2021.698721. eCollection 2021.
8
Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders.免疫缺陷和其他免疫性疾病的临床细胞流式分析方法的演变
Clin Lab Med. 2023 Sep;43(3):467-483. doi: 10.1016/j.cll.2023.05.002. Epub 2023 Jun 9.
9
The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.阿拉伯联合酋长国先天性免疫缺陷疾病谱:三级医疗中心的5年经验
Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022.
10
Primary Immunodeficiency and Thrombocytopenia.原发性免疫缺陷与血小板减少症
Int Rev Immunol. 2022;41(2):135-159. doi: 10.1080/08830185.2020.1868454. Epub 2021 Jan 19.

引用本文的文献

1
Red flags to suspect inborn errors of immunity in patients with autoimmune diseases.自身免疫性疾病患者中怀疑存在先天性免疫缺陷的警示信号。
Biomedica. 2024 Dec 23;44(Sp. 2):236-262. doi: 10.7705/biomedica.7561.
2
Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing.原发性免疫缺陷病的诊断检测:经典和遗传检测。
Allergy Asthma Proc. 2024 Sep 1;45(5):355-363. doi: 10.2500/aap.2024.45.240051.
3
Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management.免疫守护者:原发性免疫缺陷疾病及其管理的进展

本文引用的文献

1
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.人类先天性免疫缺陷:国际免疫学联盟专家委员会 2022 年更新的分类。
J Clin Immunol. 2022 Oct;42(7):1473-1507. doi: 10.1007/s10875-022-01289-3. Epub 2022 Jun 24.
2
Gain-of-function variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation.人类中的功能获得性变异会导致与异常T/B细胞晚期分化相关的免疫失调。
Sci Immunol. 2022 Mar 25;7(69):eabi7160. doi: 10.1126/sciimmunol.abi7160.
3
Decade-long leukaemia remissions with persistence of CD4 CAR T cells.
Cureus. 2023 Sep 7;15(9):e44865. doi: 10.7759/cureus.44865. eCollection 2023 Sep.
4
Co-Occurring X-Linked Agammaglobulinemia and X-Linked Chronic Granulomatous Disease: Two Isolated Pathogenic Variants in One Patient.同时发生的X连锁无丙种球蛋白血症和X连锁慢性肉芽肿病:一名患者中的两个独立致病变体。
Biomedicines. 2023 Mar 21;11(3):959. doi: 10.3390/biomedicines11030959.
5
The Role of mA Modifications in B-Cell Development and B-Cell-Related Diseases.mA 修饰在 B 细胞发育和 B 细胞相关疾病中的作用。
Int J Mol Sci. 2023 Mar 1;24(5):4721. doi: 10.3390/ijms24054721.
长达十年的白血病缓解期与 CD4 CAR T 细胞的持续存在。
Nature. 2022 Feb;602(7897):503-509. doi: 10.1038/s41586-021-04390-6. Epub 2022 Feb 2.
4
Antibodies to watch in 2022.2022 年值得关注的抗体药物
MAbs. 2022 Jan-Dec;14(1):2014296. doi: 10.1080/19420862.2021.2014296.
5
Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation.鉴定免疫失调患者 IKZF2 中的胚系单等位基因突变。
Blood Adv. 2022 Apr 12;6(7):2444-2451. doi: 10.1182/bloodadvances.2021006367.
6
Loss-of-function mutation in leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells.导致免疫缺陷的 功能丧失性突变,其特征为生发中心反应失调和 MAIT 细胞减少。
Sci Immunol. 2021 Nov 26;6(65):eabe3454. doi: 10.1126/sciimmunol.abe3454.
7
Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia.终身免疫球蛋白替代疗法与造血干细胞移植治疗丙种球蛋白缺乏症的成本效用比较。
JAMA Pediatr. 2022 Feb 1;176(2):176-184. doi: 10.1001/jamapediatrics.2021.4583.
8
T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.患者的 AIOLOS 缺陷与 T 和 B 细胞异常、肺囊虫肺炎和慢性淋巴细胞白血病有关。
J Exp Med. 2021 Dec 6;218(12). doi: 10.1084/jem.20211118. Epub 2021 Oct 25.
9
Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.生化有害的人类 NFKB1 变体是常染色体显性遗传的普通可变免疫缺陷的基础。
J Exp Med. 2021 Nov 1;218(11). doi: 10.1084/jem.20210566. Epub 2021 Sep 2.
10
Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes.与PI3Kδ过度激活相关的疾病:活化磷脂酰肌醇-3激酶δ综合征的临床和免疫学特征
Front Pediatr. 2021 Aug 5;9:702872. doi: 10.3389/fped.2021.702872. eCollection 2021.